NOL6, a new founding oncogene in human prostate cancer and targeted by miR-590-3p. Cytotechnology. -江西中医药大学中医学院

高水平论文

首页 > 组织机构 > 教学机构 > 西医教研室 > 生物化学教研室 > 高水平论文 > 正文

NOL6, a new founding oncogene in human prostate cancer and targeted by miR-590-3p. Cytotechnology.

来源：日期：2024-04-01点击：

Dong Degang, Song Mei, Wu Xiaoli, Wang Wanchun*. NOL6, a new founding oncogene in human prostate cancer and targeted by miR-590-3p. Cytotechnology. 2020;72(3):469-478.

上一篇： Lactobacillus rhamnosus FLRH93 protects against intestinal damage in mice induced by 5-fluorouracil》. J. Dairy Sci

下一篇： Oxidative stress and antioxidant defense in detoxification systems of snake venom-induced toxicity[J]. J Venom Anim Toxins Incl Trop Dis.

地址：南昌市湾里区梅岭大道1688号邮编：330004

联系电话：0791—87118931 传真：0791—87118931